Document details

Translation and cultural adaptation into Brazilian Portuguese of the Finnish diabetes risk score (Findrisc) and reliability assessment


Description

Made available in DSpace on 2020-12-12T02:44:31Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-01-01. Added 1 bitstream(s) on 2021-07-15T15:07:43Z : No. of bitstreams: 1 S1415-790X2020000100451.pdf: 1088341 bytes, checksum: 6fdb5c1dff606be92af81a3455900b51 (MD5)

Universidade Estadual Paulista

Introduction: The Finnish Diabetes Risk Score (FINDRISC) is a tool that was initially developed to predict the risk of developing type 2 diabetes mellitus in adults. This tool is simple, quick to apply, non-invasive, and low-cost. The aims of this study were to perform a translation and cultural adaptation of the original version of FINDRISC into Brazilian Portuguese and to assess test-retest reliability. Methodology: This work was done following the ISPOR Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes Measures. Once the final Brazilian Portuguese version (FINDRISC-Br) was developed, the reliability assessment was performed using a non-random sample of 83 individuals attending a primary care health center. Each participant was interviewed by trained registered dieticians on two occasions with a mean interval of 14 days. The reliability assessment was performed by analyzing the level of agreement between the test-retest responses of FINDRISC-Br using Cohen’s kappa coefficient and the intraclass correlation coefficient (ICC). Results: The steps of ISPOR guidelines were consecutively followed without major problems. Regarding the reliability assessment, the questionnaire as a whole presented adequate reliability (Cohen’s kappa = 0.82, 95%CI 0.72 – 0.92 and ICC = 0.94, 95%CI 0.91 – 0.96). Conclusion: FINDRISC was translated into Brazilian Portuguese and culturally adapted following standard procedures. FINDRISC-Br has thus become available for use and has potential as a screening tool in different Brazilian settings and applications.

Medical School Universidade Estadual Paulista (UNESP)

Texas Institute for Kidney and Endocrine Disorders

Diabetes Program Hospital Israelita Albert Einstein

Diagnosis and Therapy Support Service Beneficência Portuguesa de São Paulo

Public Health Promotion Unit National Institute for Health and Welfare

Department of Public Health University of Helsinki

Diabetes Research Group King Abdulaziz University

Institute of Biosciences Universidade Estadual Paulista (UNESP)

Medical School Universidade Estadual Paulista (UNESP)

Institute of Biosciences Universidade Estadual Paulista (UNESP)

Document Type Journal article
Language English
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents